00:37 , May 10, 2019 |  BC Innovations  |  Product Development

Congress pushes to reform patent eligibility, biotechs say not enough

Congress has taken the first step towards fixing a key problem with patent policy that has crippled the diagnostics industry and disrupted development of other life science inventions, but its proposed solution falls short for...
07:00 , Apr 28, 2014 |  BC Week In Review  |  Company News

Quest Diagnostics sales and marketing update

Quest Diagnostics' Athena Diagnostics Inc. business unit launched in the U.S. 10 lab-developed tests based on next-generation sequencing to diagnose epilepsy in children and adults. Athena launched nine panels, called Epilepsy Advanced Sequencing Evaluations, which...
07:00 , Mar 25, 2013 |  BC Week In Review  |  Company News

Quest Diagnostics sales and marketing update

Quest Diagnostics' Athena Diagnostics Inc. business unit launched a clinical test panel to help primary care physicians diagnose the cause of dementia in patients presenting with cognitive impairment. The test panel will evaluate a patient...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Company News

Quest Diagnostics sales and marketing update

Quest's Athena Diagnostics Inc. business unit launched a new genetic test in the U.S. to detect hexanucleotide repeat expansion in the chromosome 9 open reading frame 72 (C9orf72) gene as an aid to diagnose familial...
07:00 , Aug 1, 2011 |  BC Week In Review  |  Company News

Quest Diagnostics sales and marketing update

Quest launched its spinal muscular atrophy (SMA) testing services in the U.S. to diagnose SMA in patients. The tests detect defective survival of motor neuron 1 telomeric (SMN1) and the number of copies of SMN2...
07:00 , Jul 4, 2011 |  BC Week In Review  |  Company News

BG Medicine management update

BG Medicine Inc. (NASDAQ:BGMD), Waltham, Mass.   Business: Diagnostic, Proteomics, Supply/Service   Hired: Stephen Miller as chief commercial officer, a newly created position, formerly VP of sales and marketing at Athena Diagnostics Inc. , which...
07:00 , Apr 11, 2011 |  BC Week In Review  |  Company News

Quest Diagnostics, Thermo Fisher deal

Quest completed its previously announced acquisition of Thermo Fisher's Athena Diagnostics Inc. unit for $740 million in cash (see BioCentury, Feb 28). Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J.   Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham,...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Financial News

Quest Diagnostics proposes private placement of senior notes

Quest Diagnostics Inc. (NYSE: DGX), Madison, N.J.   Business: Diagnostic   Date announced: 3/21/11   Type: Private placement of senior notes   To be raised: $1.3 billion   Placement agents: Morgan Stanley; Goldman Sachs; RBS...
01:02 , Mar 22, 2011 |  BC Extra  |  Financial News

Quest planning $1.3B note deal

Quest Diagnostics Inc. (NYSE:DGX) plans to sell $1.3 billion in senior unsecured notes. Morgan Stanley; Goldman Sachs; RBS; JPMorgan; and Wells Fargo are book-running managers. Quest said it will use the proceeds to fund its...
08:00 , Feb 28, 2011 |  BC Week In Review  |  Company News

Quest Diagnostics, Thermo Fisher deal

Thermo Fisher plans to sell its Athena Diagnostics Inc. unit to Quest for $740 million. Athena, which had about $110 million in revenues last year, markets diagnostics for neurological and developmental disorders. Quest said the...